Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
BMC Neurology
|
December 3, 2021
Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review
Abril Oliva Ramirez, Alexander Keenan, Olivia Kalau, et al.
Current Medical Research and Opinion
|
March 29, 2020
The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, et al.
Current Medical Research and Opinion
|
March 30, 2020
Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, et al.
Prostate Cancer and Prostatic Diseases
|
August 17, 2023
The impact of race on survival in metastatic prostate cancer: a systematic literature review
Stephen J Freedland, Imtiaz A Samjoo, Emily Rosta, et al.
Current Medical Research and Opinion
|
August 13, 2021
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, et al.
Journal of Comparative Effectiveness Research
|
December 14, 2022
Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
Ian N Bruce, Sarowar Golam, Jason Steenkamp, et al.
Journal of Comparative Effectiveness Research
|
May 13, 2022
Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
Ian N Bruce, Sarowar Golam, Jason Steenkamp, et al.
Journal of Comparative Effectiveness Research
|
October 5, 2021
Letter in reply
Imtiaz A Samjoo, Evelyn Worthington, Christopher Drudge, et al.
Journal of Comparative Effectiveness Research
|
October 22, 2020
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis
Imtiaz A Samjoo, Evelyn Worthington, Christopher Drudge, et al.
Journal of Comparative Effectiveness Research
|
February 23, 2021
Efficacy classification of modern therapies in multiple sclerosis
Imtiaz A Samjoo, Evelyn Worthington, Christopher Drudge, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
BMC Neurology
|
December 3, 2021
Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review
Abril Oliva Ramirez, Alexander Keenan, Olivia Kalau, et al.
Current Medical Research and Opinion
|
March 29, 2020
The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, et al.
Current Medical Research and Opinion
|
March 30, 2020
Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, et al.
Prostate Cancer and Prostatic Diseases
|
August 17, 2023
The impact of race on survival in metastatic prostate cancer: a systematic literature review
Stephen J Freedland, Imtiaz A Samjoo, Emily Rosta, et al.
Current Medical Research and Opinion
|
August 13, 2021
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, et al.
Journal of Comparative Effectiveness Research
|
December 14, 2022
Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
Ian N Bruce, Sarowar Golam, Jason Steenkamp, et al.
Journal of Comparative Effectiveness Research
|
May 13, 2022
Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
Ian N Bruce, Sarowar Golam, Jason Steenkamp, et al.
Journal of Comparative Effectiveness Research
|
October 5, 2021
Letter in reply
Imtiaz A Samjoo, Evelyn Worthington, Christopher Drudge, et al.
Journal of Comparative Effectiveness Research
|
October 22, 2020
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis
Imtiaz A Samjoo, Evelyn Worthington, Christopher Drudge, et al.
Journal of Comparative Effectiveness Research
|
February 23, 2021
Efficacy classification of modern therapies in multiple sclerosis
Imtiaz A Samjoo, Evelyn Worthington, Christopher Drudge, et al.
Page
of 2